Image may be NSFW.
Clik here to view.
Clik here to view.
Mati Therapeutics isn’t your traditional biotech startup
Not quite two years old yet, closely held Mati Therapeutics is conducting a pre-Phase 3 clinical trial with an ocular punctal plug delivery system (PPDS) that could become a preferred alternative to...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Ocular Therapeutix eyeing sustained drug delivery
Ocular Therapeutix (NASDAQ:OCUL) is aiming to transform the treatment of eye diseases with sustained-release therapeutics, creating a paradigm shift from frequently administered topical ophthalmic...
View Article
More Pages to Explore .....
